Analysen zu BioNTech (ADRs)
| 09.09.24 | BioNTech Underweight | JP Morgan Chase & Co. | |
| 16.08.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 16.08.24 | BioNTech Underweight | JP Morgan Chase & Co. | |
| 06.08.24 | BioNTech Neutral | Goldman Sachs Group Inc. | |
| 05.08.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 24.05.24 | BioNTech Hold | Deutsche Bank AG | |
| 10.05.24 | BioNTech Neutral | UBS AG | |
| 08.05.24 | BioNTech Hold | Deutsche Bank AG | |
| 07.05.24 | BioNTech Neutral | Goldman Sachs Group Inc. | |
| 06.05.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 23.04.24 | BioNTech Hold | Deutsche Bank AG | |
| 22.03.24 | BioNTech Hold | Deutsche Bank AG | |
| 21.03.24 | BioNTech Hold | Deutsche Bank AG | |
| 21.03.24 | BioNTech Neutral | Goldman Sachs Group Inc. | |
| 20.03.24 | BioNTech Hold | Jefferies & Company Inc. | |
| 20.03.24 | BioNTech Neutral | UBS AG | |
| 09.01.24 | BioNTech Neutral | UBS AG | |
| 14.12.23 | BioNTech Neutral | UBS AG | |
| 12.12.23 | BioNTech Hold | Jefferies & Company Inc. | |
| 28.11.23 | BioNTech Neutral | UBS AG | |
| 08.11.23 | BioNTech Neutral | Goldman Sachs Group Inc. | |
| 07.11.23 | BioNTech Neutral | Goldman Sachs Group Inc. | |
| 30.10.23 | BioNTech Neutral | JP Morgan Chase & Co. | |
| 16.10.23 | BioNTech Neutral | UBS AG | |
| 06.09.23 | BioNTech Hold | Jefferies & Company Inc. |
Aktuelle Aktienanalysen
| 04.09.25 | DEUTZ Buy | Hauck Aufhäuser Lampe Privatbank AG | |
| 04.09.25 | AUTO1 Buy | Goldman Sachs Group Inc. | |
| 04.09.25 | Siemens Healthineers Buy | Jefferies & Company Inc. | |
| 04.09.25 | Siemens Energy Underperform | Bernstein Research | |
| 04.09.25 | Continental Underperform | Bernstein Research | |
| 04.09.25 | Holcim Buy | Goldman Sachs Group Inc. | |
| 04.09.25 | Heidelberg Materials Buy | Goldman Sachs Group Inc. | |
| 04.09.25 | Schneider Electric Outperform | Bernstein Research | |
| 04.09.25 | Andritz kaufen | Erste Group Bank | |
| 04.09.25 | Apple Neutral | UBS AG | |
| 04.09.25 | Unilever Sell | UBS AG | |
| 04.09.25 | Sanofi Buy | Jefferies & Company Inc. | |
| 04.09.25 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | Continental Buy | UBS AG | |
| 04.09.25 | Ceconomy St. Sell | Warburg Research | |
| 04.09.25 | Roche Buy | UBS AG | |
| 04.09.25 | LVMH Moet Hennessy Louis Vuitton Neutral | JP Morgan Chase & Co. | |
| 04.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | Fraport Neutral | JP Morgan Chase & Co. | |
| 04.09.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | Salesforce Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | Salesforce Neutral | UBS AG | |
| 04.09.25 | RWE Outperform | Bernstein Research | |
| 04.09.25 | Heidelberg Materials Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | SAP Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | Continental Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | Rolls-Royce Buy | UBS AG | |
| 04.09.25 | SAFRAN Neutral | UBS AG | |
| 04.09.25 | Airbus Buy | UBS AG | |
| 04.09.25 | MTU Aero Engines Neutral | UBS AG | |
| 04.09.25 | SMA Solar Hold | Jefferies & Company Inc. | |
| 03.09.25 | Nestlé Hold | Jefferies & Company Inc. | |
| 03.09.25 | Unilever Underperform | Jefferies & Company Inc. | |
| 03.09.25 | SAP Overweight | JP Morgan Chase & Co. | |
| 03.09.25 | UniCredit Kaufen | DZ BANK | |
| 03.09.25 | DocMorris Buy | Jefferies & Company Inc. | |
| 03.09.25 | Redcare Pharmacy Buy | Jefferies & Company Inc. | |
| 03.09.25 | Shell Buy | UBS AG | |
| 03.09.25 | Alphabet A Neutral | UBS AG | |
| 03.09.25 | PVA TePla Buy | Jefferies & Company Inc. | |
| 03.09.25 | UBM Development kaufen | Warburg Research | |
| 03.09.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 03.09.25 | Alphabet A Overweight | JP Morgan Chase & Co. | |
| 03.09.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
| 03.09.25 | Nestlé Hold | Deutsche Bank AG | |
| 03.09.25 | WACKER CHEMIE Hold | Deutsche Bank AG | |
| 03.09.25 | SMA Solar Hold | Deutsche Bank AG | |
| 03.09.25 | PVA TePla Buy | Deutsche Bank AG | |
| 03.09.25 | McDonald's Buy | UBS AG | |
| 03.09.25 | SAP Overweight | Barclays Capital |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.